1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Medical Second Opinion Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe Medical Second Opinion Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Growing emphasis on better treatment outcomes Favors Market Growth
5.2 Market Opportunities
- 5.2.1 Increasing collaborations in telemedicine technologies are likely to create ample opportunities in the coming years
5.3 Future Trends
- 5.3.1 Increasing digitalization of medical consulting services expected to be the future trends in coming years
5.4 Impact of Drivers and Restraints
6. Europe Medical Second Opinion Market Regional Analysis
6.1 Europe Medical Second Opinion Market Overview
6.2 Europe Medical Second Opinion Market Revenue 2018-2027 (US$ Million)
6.3 Europe Medical Second Opinion Market Forecast Analysis
7. Europe Medical Second Opinion Market Analysis – by Disorders
7.1 Cancer
- 7.1.1 Overview
- 7.1.2 Cancer: Europe Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Orthopedic Disorders
- 7.2.1 Overview
- 7.2.2 Orthopedic Disorders: Europe Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Cardiac Disorders
- 7.3.1 Overview
- 7.3.2 Cardiac Disorders: Europe Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Neurological Disorders
- 7.4.1 Overview
- 7.4.2 Neurological Disorders: Europe Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Nephrological Disorders
- 7.5.1 Overview
- 7.5.2 Nephrological Disorders: Europe Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Hematologic Blood Disorders
- 7.6.1 Overview
- 7.6.2 Hematologic Blood Disorders: Europe Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
7.7 COPD
- 7.7.1 Overview
- 7.7.2 COPD: Europe Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
7.8 Organ transplant
- 7.8.1 Overview
- 7.8.2 Organ transplant: Europe Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
7.9 Other Disorders
- 7.9.1 Overview
- 7.9.2 Other Disorders: Europe Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Medical Second Opinion Market Analysis – by Service Providers
8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Hospitals: Europe Medical Second Opinion Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Health Insurance Companies
- 8.2.1 Overview
- 8.2.2 Health Insurance Companies: Europe Medical Second Opinion Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Online Services
- 8.3.1 Overview
- 8.3.2 Online Services : Europe Medical Second Opinion Market – Revenue and Forecast to 2027 (US$ Million)
9. Europe Medical Second Opinion Market – Europe Analysis
9.1 Europe
- 9.1.1 Europe Medical Second Opinion Market Breakdown, by Key
Country, 2021 and 2027 (%)
- 9.1.1.1 Europe Medical Second Opinion Market – Revenue and
Forecast Analysis – by Country
- 9.1.1.1 UK:
Europe Medical Second Opinion Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.1.1 UK: Europe Medical Second Opinion Market Breakdown, by Disorders
- 9.1.1.1.2 UK: Europe Medical Second Opinion Market Breakdown, by Service Providers
- 9.1.1.2 Germany:
Europe Medical Second Opinion Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.2.1 Germany: Europe Medical Second Opinion Market Breakdown, by Disorders
- 9.1.1.2.2 Germany: Europe Medical Second Opinion Market Breakdown, by Service Providers
- 9.1.1.3 France:
Europe Medical Second Opinion Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.3.1 France: Europe Medical Second Opinion Market Breakdown, by Disorders
- 9.1.1.3.2 France: Europe Medical Second Opinion Market Breakdown, by Service Providers
- 9.1.1.4 Russia:
Europe Medical Second Opinion Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.4.1 Russia: Europe Medical Second Opinion Market Breakdown, by Disorders
- 9.1.1.4.2 Russia: Europe Medical Second Opinion Market Breakdown, by Service Providers
- 9.1.1.5 Italy:
Europe Medical Second Opinion Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.5.1 Italy: Europe Medical Second Opinion Market Breakdown, by Disorders
- 9.1.1.5.2 Italy: Europe Medical Second Opinion Market Breakdown, by Service Providers
- 9.1.1.6 Rest of Europe:
Europe Medical Second Opinion Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.6.1 Rest of Europe: Europe Medical Second Opinion Market Breakdown, by Disorders
- 9.1.1.6.2 Rest of Europe: Europe Medical Second Opinion Market Breakdown, by Service Providers
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Europe Medical Second Opinion Market Industry Landscape
11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments
12. Company Profiles
12.1 Second Opinion International
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Elite Medical Services
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Helsana
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Cigna
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 WorldCare
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Medix
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 2nd.MD (Innovation Specialists LLC)
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 AXA
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
13. Appendix
13.1 About Business Market Insights
Get Free Sample For Europe Medical Second Opinion Market
